Evidence map›Paper›PMID 40282414›Full record

ArticleGenes2025

Population-Specific Differences in Pathogenic Variants of Genes Associated with Monogenic Parkinson's Disease.

Victor Flores-Ocampo, Amanda Wei-Yin Lim, Natalia S Ogonowski, Luis M García-Marín, Jue-Sheng Ong, Dennis Yeow, Claudia Gonzaga-Jauregui, Kishore R Kumar, Miguel E Rentería

Abstract read
In one paragraph

Article in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Genomic Landscape of Early-Onset and Familial Latin American Parkinson's Patients.medRxiv : the preprint server for health sciences · 2026
    Article
  2. Genetic and environmental risk factors of Parkinsonism.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Victor Flores-OcampoBrain & Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Amanda Wei-Yin LimBrain & Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.ORCID 0000-0002-2612-0604
Natalia S OgonowskiBrain & Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Luis M García-MarínBrain & Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Jue-Sheng OngPopulation Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Dennis YeowMolecular Medicine Laboratory, Concord Repatriation General Hospital, Concord, NSW 2139, Australia.
Claudia Gonzaga-JaureguiLaboratorio Internacional de Investigación sobre el Genoma Humano, Universidad Nacional Autónoma de México, Juriquilla 76230, Querétaro, Mexico.ORCID 0000-0002-4667-3679
Kishore R KumarMolecular Medicine Laboratory, Concord Repatriation General Hospital, Concord, NSW 2139, Australia.ORCID 0000-0003-3482-6962
Miguel E RenteríaBrain & Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.ORCID 0000-0003-4626-7248

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParkinson's disease (PD) is a genetically complex neurodegenerative disorder. Up to 15% of cases are considered monogenic. However, research on monogenic PD has largely focused on populations of European ancestry, leaving gaps in our understanding of genetic variability in other populations. This study addresses this gap by analysing the allele frequencies of pathogenic and likely pathogenic variants in known monogenic PD genes across eight global populations, using data from the gnomAD database.

methodsWe compiled a list of 27 genes associated with Mendelian PD from the Online Mendelian Inheritance in Man (OMIM) database, and identified pathogenic and likely pathogenic variants using ClinVar. We then performed pairwise comparisons of allele frequencies across populations included in the gnomAD database. Variants with significant frequency differences were further assessed using in silico pathogenicity predictions.

resultsWe identified 81 variants across 17 genes with statistically significant allele frequency differences between at least two populations. Variants in

conclusionsOur findings reveal substantial population-specific differences in the allele frequencies of pathogenic variants linked to monogenic PD, emphasising the need for broader genetic studies beyond European populations. These insights have important implications for PD research, genetic screening, and understanding the pathogenesis of PD in diverse populations.

Indexed as

Genetic Predisposition to DiseaseParkinson DiseaseAmishAsian PeopleBlack PeopleDatabases, GeneticGene FrequencyGenetic VariationGlucosylceramidaseGroup VI Phospholipases A2HumansJewsProton-Translocating ATPasesWhite PeopleATP13A2 protein, humanGBA protein, humanGlucosylceramidaseGroup VI Phospholipases A2PLA2G6 protein, humanProton-Translocating ATPasesfamilial Parkinson’s diseaseglobal populationsgnomADmonogenic Parkinsonpathogenic variants

Identifiers

PMID40282414
PMCPMC12027003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.